Molecular pharming’s foot in the FDA’s door: Protalix’s trailblazing story

Tsafrir Leket-Mor

Research output: Contribution to journal › Review article › peer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Molecular pharming’s foot in the FDA’s door: Protalix’s trailblazing story'. Together they form a unique fingerprint.

Medicine & Life Sciences

Engineering & Materials Science

Chemical Compounds